GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Enterprise Value

Biophytis (Biophytis) Enterprise Value : $2.33 Mil (As of May. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biophytis Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biophytis's Enterprise Value is $2.33 Mil. Biophytis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.32 Mil. Therefore, Biophytis's EV-to-EBIT ratio for today is -0.13.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biophytis's Enterprise Value is $2.33 Mil. Biophytis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-16.45 Mil. Therefore, Biophytis's EV-to-EBITDA ratio for today is -0.14.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biophytis's Enterprise Value is $2.33 Mil. Biophytis's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Biophytis's EV-to-Revenue ratio for today is .


Biophytis Enterprise Value Historical Data

The historical data trend for Biophytis's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Enterprise Value Chart

Biophytis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 59.18 9.19 7.10

Biophytis Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.18 12.41 9.19 13.39 7.10

Competitive Comparison of Biophytis's Enterprise Value

For the Biotechnology subindustry, Biophytis's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biophytis's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biophytis's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Biophytis's Enterprise Value falls into.



Biophytis Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Biophytis's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Biophytis's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biophytis  (OTCPK:BPTSY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Biophytis's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.330/-17.324
=-0.13

Biophytis's current Enterprise Value is $2.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biophytis's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.32 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Biophytis's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2.330/-16.45
=-0.14

Biophytis's current Enterprise Value is $2.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biophytis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-16.45 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Biophytis's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.330/0
=

Biophytis's current Enterprise Value is $2.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biophytis's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biophytis Enterprise Value Related Terms

Thank you for viewing the detailed overview of Biophytis's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biophytis (Biophytis) Business Description

Traded in Other Exchanges
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.